Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Portal Hypertension in Noncirrhotic Patients with Portal Cavernoma

Background. The purpose of this study was to evaluate the safety and efficacy of transjugular intrahepatic portosystemic shunt (TIPS) placement in the management of portal hypertension in noncirrhotic patients with portal cavernoma. Methods. We conducted a single institution retrospective analysis o...

Full description

Saved in:
Bibliographic Details
Main Authors: Xuefeng Luo, Ling Nie, Biao Zhou, Denghua Yao, Huaiyuan Ma, Mingshan Jiang, Hailong Zhang, Xiao Li
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2014/659726
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841524616187609088
author Xuefeng Luo
Ling Nie
Biao Zhou
Denghua Yao
Huaiyuan Ma
Mingshan Jiang
Hailong Zhang
Xiao Li
author_facet Xuefeng Luo
Ling Nie
Biao Zhou
Denghua Yao
Huaiyuan Ma
Mingshan Jiang
Hailong Zhang
Xiao Li
author_sort Xuefeng Luo
collection DOAJ
description Background. The purpose of this study was to evaluate the safety and efficacy of transjugular intrahepatic portosystemic shunt (TIPS) placement in the management of portal hypertension in noncirrhotic patients with portal cavernoma. Methods. We conducted a single institution retrospective analysis of 15 noncirrhotic patients with portal cavernoma treated with TIPS placement. 15 patients (4 women and 11 men) were evaluated via the technical success of TIPS placement, procedural complications, and follow-up shunt patency. Results. TIPS placement was technically successful in 11 out of 15 patients (73.3%). Procedure-related complications were limited to a single instance of hepatic encephalopathy in one patient. In patients with successful shunt placement, the portal pressure gradient decreased from 25.8±5.7 to 9.5±4.2 mmHg (P<0.001). TIPS dysfunction occurred in two patients during a median follow-up time of 45.2 months. Revision was not performed in one patient due to inadequate inflow. The other patient died of massive gastrointestinal bleeding in a local hospital. The remaining nine patients maintained functioning shunts through their last evaluation. Conclusions. TIPS is a safe and effective therapeutic treatment for noncirrhotic patients with symptomatic portal hypertension secondary to portal cavernoma.
format Article
id doaj-art-4e75e981e15844e193d65efff7d615fe
institution Kabale University
issn 1687-6121
1687-630X
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-4e75e981e15844e193d65efff7d615fe2025-02-03T05:47:46ZengWileyGastroenterology Research and Practice1687-61211687-630X2014-01-01201410.1155/2014/659726659726Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Portal Hypertension in Noncirrhotic Patients with Portal CavernomaXuefeng Luo0Ling Nie1Biao Zhou2Denghua Yao3Huaiyuan Ma4Mingshan Jiang5Hailong Zhang6Xiao Li7Center of Interventional Radiology, West China Hospital, Sichuan University, 37 Guoxue Lane, Chengdu, Sichuan 610041, ChinaCenter of Interventional Radiology, West China Hospital, Sichuan University, 37 Guoxue Lane, Chengdu, Sichuan 610041, ChinaCenter of Interventional Radiology, West China Hospital, Sichuan University, 37 Guoxue Lane, Chengdu, Sichuan 610041, ChinaCenter of Interventional Radiology, West China Hospital, Sichuan University, 37 Guoxue Lane, Chengdu, Sichuan 610041, ChinaCenter of Interventional Radiology, West China Hospital, Sichuan University, 37 Guoxue Lane, Chengdu, Sichuan 610041, ChinaCenter of Interventional Radiology, West China Hospital, Sichuan University, 37 Guoxue Lane, Chengdu, Sichuan 610041, ChinaCenter of Interventional Radiology, West China Hospital, Sichuan University, 37 Guoxue Lane, Chengdu, Sichuan 610041, ChinaCenter of Interventional Radiology, West China Hospital, Sichuan University, 37 Guoxue Lane, Chengdu, Sichuan 610041, ChinaBackground. The purpose of this study was to evaluate the safety and efficacy of transjugular intrahepatic portosystemic shunt (TIPS) placement in the management of portal hypertension in noncirrhotic patients with portal cavernoma. Methods. We conducted a single institution retrospective analysis of 15 noncirrhotic patients with portal cavernoma treated with TIPS placement. 15 patients (4 women and 11 men) were evaluated via the technical success of TIPS placement, procedural complications, and follow-up shunt patency. Results. TIPS placement was technically successful in 11 out of 15 patients (73.3%). Procedure-related complications were limited to a single instance of hepatic encephalopathy in one patient. In patients with successful shunt placement, the portal pressure gradient decreased from 25.8±5.7 to 9.5±4.2 mmHg (P<0.001). TIPS dysfunction occurred in two patients during a median follow-up time of 45.2 months. Revision was not performed in one patient due to inadequate inflow. The other patient died of massive gastrointestinal bleeding in a local hospital. The remaining nine patients maintained functioning shunts through their last evaluation. Conclusions. TIPS is a safe and effective therapeutic treatment for noncirrhotic patients with symptomatic portal hypertension secondary to portal cavernoma.http://dx.doi.org/10.1155/2014/659726
spellingShingle Xuefeng Luo
Ling Nie
Biao Zhou
Denghua Yao
Huaiyuan Ma
Mingshan Jiang
Hailong Zhang
Xiao Li
Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Portal Hypertension in Noncirrhotic Patients with Portal Cavernoma
Gastroenterology Research and Practice
title Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Portal Hypertension in Noncirrhotic Patients with Portal Cavernoma
title_full Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Portal Hypertension in Noncirrhotic Patients with Portal Cavernoma
title_fullStr Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Portal Hypertension in Noncirrhotic Patients with Portal Cavernoma
title_full_unstemmed Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Portal Hypertension in Noncirrhotic Patients with Portal Cavernoma
title_short Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Portal Hypertension in Noncirrhotic Patients with Portal Cavernoma
title_sort transjugular intrahepatic portosystemic shunt for the treatment of portal hypertension in noncirrhotic patients with portal cavernoma
url http://dx.doi.org/10.1155/2014/659726
work_keys_str_mv AT xuefengluo transjugularintrahepaticportosystemicshuntforthetreatmentofportalhypertensioninnoncirrhoticpatientswithportalcavernoma
AT lingnie transjugularintrahepaticportosystemicshuntforthetreatmentofportalhypertensioninnoncirrhoticpatientswithportalcavernoma
AT biaozhou transjugularintrahepaticportosystemicshuntforthetreatmentofportalhypertensioninnoncirrhoticpatientswithportalcavernoma
AT denghuayao transjugularintrahepaticportosystemicshuntforthetreatmentofportalhypertensioninnoncirrhoticpatientswithportalcavernoma
AT huaiyuanma transjugularintrahepaticportosystemicshuntforthetreatmentofportalhypertensioninnoncirrhoticpatientswithportalcavernoma
AT mingshanjiang transjugularintrahepaticportosystemicshuntforthetreatmentofportalhypertensioninnoncirrhoticpatientswithportalcavernoma
AT hailongzhang transjugularintrahepaticportosystemicshuntforthetreatmentofportalhypertensioninnoncirrhoticpatientswithportalcavernoma
AT xiaoli transjugularintrahepaticportosystemicshuntforthetreatmentofportalhypertensioninnoncirrhoticpatientswithportalcavernoma